Literature DB >> 11988190

Aortic valve sclerosis, mitral annular calcium, and aortic root sclerosis as markers of atherosclerosis in men.

Kirsten Tolstrup1, Carlos A Roldan, Clifford R Qualls, Michael H Crawford.   

Abstract

Aortic valve sclerosis (AVS) and mitral annular calcium (MAC) as detected by transthoracic echocardiography have been associated with atherosclerosis. Aortic root sclerosis (ARS) may have a similar association, but has not been studied. This study evaluates, by transesophageal echocardiography, the association of AVS, MAC, and ARS with aortic atheromatous disease and cardiovascular disease. Multiplane transesophageal echocardiography with evaluation of AVS, MAC, ARS, and aortic atheromatous disease by 2 experienced observers unaware of clinical data was performed in 157 male patients > or =50 years old. The presence of cardiovascular disease, defined as coronary, carotid, or peripheral artery disease, was determined by specific criteria. The prevalence of AVS, MAC, ARS, and aortic atheromatous disease was 42%, 30%, 48%, and 71%, respectively. The presence of AVS, MAC, or ARS was highly associated with aortic atheromatous disease (odds ratio 4.9 to 12.0, confidence interval 1.4 to 35.8, p <0.001). ARS was also associated with cardiovascular disease (odds ratio 2.2, confidence interval 1.0 to 4.5, p = 0.038). The presence of AVS, MAC, or ARS had a sensitivity of 77%, specificity of 72%, a positive predictive value of 88%, and a negative predictive value of 55% for aortic atheromatous disease. We concluded that the prevalence of AVS, MAC, or ARS by transesophageal echocardiography in men is common, and their presence is highly associated with aortic atheromatous disease and coronary, carotid, or peripheral artery disease.

Entities:  

Mesh:

Year:  2002        PMID: 11988190     DOI: 10.1016/s0002-9149(02)02270-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients.

Authors:  Andrea Rossi; Pompilio Faggiano; Alexandra E Amado; Mariantonietta Cicoira; Stefano Bonapace; Lorenzo Franceschini; Frank L Dini; Stefano Ghio; Eustachio Agricola; Pier Luigi Temporelli; Corrado Vassanelli
Journal:  Heart Vessels       Date:  2013-11-07       Impact factor: 2.037

2.  Aortic valve area: meta-analysis of diagnostic performance of multi-detector computed tomography for aortic valve area measurements as compared to transthoracic echocardiography.

Authors:  Rajnil G Shah; Gian M Novaro; Rodolfo J Blandon; Mitchell S Whiteman; Craig R Asher; Jacobo Kirsch
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-07       Impact factor: 2.357

3.  Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes.

Authors:  Andrea Rossi; Giovanni Targher; Giacomo Zoppini; Mariantonietta Cicoira; Stefano Bonapace; Carlo Negri; Vincenzo Stoico; Pompilio Faggiano; Corrado Vassanelli; Enzo Bonora
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

4.  Mitral annular calcification predicts immediate results of percutaneous transvenous mitral commissurotomy.

Authors:  Mojtaba Salarifar; Mehrnaz Rezvanfard; Hakimeh Sadeghian; Azam Safir-mardanloo; Nahid Shafii
Journal:  Cardiovasc Ultrasound       Date:  2011-10-28       Impact factor: 2.062

5.  Aortic Valve Sclerosis on Echocardiography is a Good Predictor of Coronary Artery Disease in Patients With an Inconclusive Treadmill Exercise Test.

Authors:  Dong-Bin Kim; Hae-Ok Jung; Doo-Soo Jeon; Chan-Seok Park; Sung-Won Jang; Hoon-Joon Park; Pum Joon Kim; Sang Hong Baek; Ki-Bae Seung; Tai-Ho Rho; Jae-Hyung Kim; Kyu-Bo Choi
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

6.  Real-time imaging required for optimal echocardiographic assessment of aortic valve calcification.

Authors:  Mohamed Yousry; Anette Rickenlund; Johan Petrini; Tomas Gustavsson; Ulrica Prahl; Jan Liska; Per Eriksson; Anders Franco-Cereceda; Maria J Eriksson; Kenneth Caidahl
Journal:  Clin Physiol Funct Imaging       Date:  2012-07-29       Impact factor: 2.273

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.